Debra Zack Exagen Inc. (XGN) insider trading activity

XGN Quotes by TradingView

Debra Zack is Chief Medical Officer of EXAGEN INC.. Currently has a direct ownership of 84,259 shares of XGN, which is worth approximately $204,749. The most recent transaction as insider was on Mar 01, 2022, when has been sold 3,241 shares (Common Stock) at a price of $7.12 per share, resulting in proceeds of $23,076. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 84.3K
0% 3M change
0% 12M change
Total Value Held $204,749

Debra Zack Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2022
SELL
Payment of exercise price or tax liability
$23,076 $7.12 p/Share
3,241 Reduced 3.7%
84,259 Common Stock
Feb 04 2022
BUY
Grant, award, or other acquisition
-
50,000 Added 36.36%
87,500 Common Stock
Feb 23 2021
BUY
Grant, award, or other acquisition
-
37,500 Added 50.0%
37,500 Common Stock
DZ

Debra Zack

Chief Medical Officer
Vista, CA

Track Institutional and Insider Activities on XGN

Follow EXAGEN INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XGN shares.

Notify only if

Insider Trading

Get notified when an Exagen Inc. insider buys or sells XGN shares.

Notify only if

News

Receive news related to EXAGEN INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XGN